Deep experience to guide your innovation

Xontogeny’s team has experience across scientific diligence, drug and medical technology development and operations from preclinical stages through commercialization. Through the efforts of the team, Xontogeny supports and stays connected with its entrepreneurs and larger community of collaborators by providing strategic and investment leadership to create successful outcomes across its portfolio of companies.


Chris Garabedian

Chairman & CEO

Fred Callori

Senior Partner

Gianna Hoffman-Luca, Ph.D.


Katherine Ruf​

General Counsel

Takeru Furuya, Ph.D.


Heather Antioquia

Senior Director, Program Development

Thien Nguyen, Ph.D.

Senior Associate

Jayanth Batchu

Senior Analyst / EIR

Maggie Clarkeson-Carroll

Executive Administrator

Brad Murray


Holly Purcell


Melissa Rewolinski, Ph.D.

R&D Advisor

Ann Taylor, M.D.

R&D Advisor

Ben Green

Digital Strategy Advisor

Dana Leone


Robin Wallace

Clinical Operations Advisor


Chris Garabedian

Chris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof of concept.

Joe Edelman

Joe Edelman founded the hedge fund Perceptive Advisors, LLC in 1999, to further the progress of promising companies within the life sciences industry.

Adam Stone

Adam Stone joined Perceptive Advisors, a hedge fund focused on supporting the progress of the life sciences industry, in 2006.